+Vote!
Red Orbit (Free subscription) | 07/23/2008
After 50 years of service in modern medicine, hematology analyzers have a strong reputation to live up to. Customers are well acquainted with the product and scrutinize every aspect of testing and expect optimum test solutions for their laboratories. Manufacturers are compelled to live up to these high expectations by continuously innovating and delivering a broad range of products and services due...
+Vote!
GadBall.com (Free subscription) | 07/14/2008
PA HematologyOncology. Hospital is searching for a third Medical Oncologist for their program. This facility is a 168 bed hospital located northwest of Philadelphia. A comprehensive financial package is being offered that may include Medical education debt repayment and a commencement bonus. If you are interested in this opportunity, contact Linda Smith directly at 888-333-4585. To expedite the recruiting...
3Vote!
Medical News Today (Free subscription) | 07/09/2008
The American Society of Hematology (ASH) is proud to announce the inaugural recipients of its Alternative Training Pathway Grant. The grant is given to training program directors to encourage the development and implementation of novel hematology-related training programs. Thomas Abshire, MD, of Emory University, Donald Mahoney Jr.
2Vote!
Medical News Today (Free subscription) | 07/07/2008
Counting the number of tumor cells circulating in the bloodstream of patients with castration-resistant prostate cancer can accurately predict how well they are responding to treatment, new results show. At the ESMO Conference Lugano (ECLU) organized by the European Society for Medical Oncology, researchers showed that changes in the number of circulating tumor cells predicted the outcome after chemotherapy...
+Vote!
Food and Drug Adminstration (FDA): CDRHNew (Free subscription) | 07/07/2008
The committee will discuss and make recommendations on issues relevant to the potential for automated differential cell counters being waived under the Clinical Laboratory Improvement Amendments of 1988. The discussion will include pre-analytical, a...
+Vote!
Medical News Today (Free subscription) | 07/05/2008
Twenty hematology and hematology/oncology fellows and junior faculty will begin a unique year-long education and mentoring program this summer as part of the American Society of Hematology (ASH) Clinical Research Training Institute. Each year, the Clinical Research Training Institute provides aspiring hematologists with the necessary tools to begin careers in clinical research.
2Vote!
Red Orbit (Free subscription) | 07/02/2008
Bayer HealthCare is expanding its commitment to hemophilia with the acquisition of Maxygen's (NASDAQ:MAXY) hemophilia program assets, including a next-generation recombinant Factor VIIa protein known as MAXY-VII.
+Vote!
The Earth Times Online Newspaper (Free subscription) | 07/02/2008
LEVERKUSEN, Germany & REDWOOD CITY, Calif. - Bayer HealthCare is expanding its commitment to hemophilia with the acquisition of Maxygen’s (NASDAQ:MAXY) hemophilia program assets, including a next-generation recombinant Factor VIIa protein known as M
1Vote!
Business Wire (Free subscription) | 07/02/2008
LEVERKUSEN, Germany & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Bayer HealthCare is expanding its commitment to hemophilia with the acquisition of Maxygen’s
1Vote!
Medical News Today (Free subscription) | 06/28/2008
AspenBio Pharma, Inc. (NASDAQ: APPY) an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has officially initiated a clinical trial to support the FDA 510(k) application for the AppyScore™ Human Appendicitis blood-based diagnostic test. Enrollment of the first patients in the independent, blind, multicenter study began this week,...
+Vote!
Medical News Today (Free subscription) | 06/26/2008
Instrumentation Laboratory (IL) announced that it has received FDA clearance 510(k) for the ACL TOP software V3.0.0. This clearance allows IL to market the ACL TOP 500 CTS Hemostasis Testing System in the United States as a member of the ACL TOP Family of analyzers.
1Vote!
Medical News Today (Free subscription) | 06/26/2008
MediQuest Therapeutics Inc. announced that it has been granted priority review status from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for MQX-503, a topical formulation designed to treat Raynaud's Disease. A priority review provides the opportunity for an approvability decision by the FDA within six months instead of the standard ten months or more. "Currently, there...
+Vote!
Medical News Today (Free subscription) | 06/24/2008
The U.S. Pharmacopeial (USP) Convention announces that revised monographs for heparin sodium and heparin calcium in the United States Pharmacopeia (USP) are now available and official on the USP Web site. The revised monographs are accompanied by two new and two updated official USP Reference Standards.
1Vote!
Medical News Today (Free subscription) | 06/19/2008
Data from the ECOG E4A03 and SWOG 0232 studies were reported at a Satellite Symposium and showed that newly diagnosed multiple myeloma patients who are eligible for a transplant, obtain better outcomes when treated with REVLIMID (lenalidomide) plus dexamethasone. The data were presented by Dr A.
